Related Experiment Videos
Subglottic injury: a clinically relevant animal model
Nicola A Kelly1, Madeline Murphy, Seamus Giles
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. nicola.kelly@ucdconnect.ie
The Laryngoscope
|September 11, 2012
Summary
A new rabbit model reliably reproduces subglottic injury from intubation, showing inflammation and tissue changes. This model aids research into preventing acquired subglottic stenosis.
Area of Science:
- Otorhinolaryngology
- Pathology
- Animal Models
Background:
- Endotracheal intubation can lead to subglottic stenosis (SGS).
- Developing a reproducible animal model is crucial for studying SGS pathogenesis and testing interventions.
- Existing models may not fully capture the acute/subacute injury spectrum.
Purpose of the Study:
- To establish a clinically relevant and reproducible animal model for subglottic injury.
- To investigate the histological and morphometric changes following intubation in a juvenile rabbit model.
- To provide a foundation for future studies on preventing or treating acquired subglottic stenosis.
Main Methods:
- Prospective randomized control pilot study using juvenile New Zealand White rabbits.
- Intubation with oversized endotracheal tubes for 1 week, followed by sacrifice and larynges harvest.
- Histological techniques and gross morphology analysis to assess subglottic injury, with unintubated animals as controls.
Main Results:
- Intubated rabbits showed significant histopathology: ulceration, inflammation, granulation tissue, perichondritis, and chondritis.
- Increased lamina propria thickness (P = .0013), mucosal thickness (P ≤ .0001), and goblet cell density (P = .014).
- Significant decrease in acidic mucin (P = .0001) and increase in mixed mucin types (P = .0013).
Conclusions:
- The developed rabbit model reliably replicates acute/subacute subglottic injury from intubation.
- Findings align with early histological changes observed in acquired subglottic stenosis.
- This model can be used to evaluate therapies aimed at limiting SGS progression.